Gene · 5469
Papers2,516
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,516
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Current Therapeutic Role of Chromatin Remodeling for the Prognosis and Treatment of Heart Failure. | Biomedicines | 2023 | 36831115 | PubTator, text mining | PubMed |
| Through the lens of phase separation: intrinsically unstructured protein and chromatin looping. | Nucleus | 2023 | 36821650 | PubTator, text mining | PubMed |
| Transcriptome analysis creates a new era of precision medicine for managing recurrent hepatocellular carcinoma. | World J Gastroenterol | 2023 | 36816628 | PubTator, text mining | PubMed |
| eRNA profiling uncovers the enhancer landscape of oesophageal adenocarcinoma and reveals new deregulated pathways. | Elife | 2023 | 36803948 | PubTator, text mining | PubMed |
| Proximity labeling reveals a new in vivo network of interactors for the histone demethylase KDM5. | Epigenetics Chromatin | 2023 | 36803422 | PubTator, text mining | PubMed |
| Emerging landscape of circFNDC3B and its role in human malignancies. | Front Oncol | 2023 | 36793611 | PubTator, text mining | PubMed |
| MED27 plays a tumor-promoting role in breast cancer progression by targeting KLF4. | Cancer Sci | 2023 | 36786527 | PubTator, text mining | PubMed |
| Genomic targets of the IRE1-XBP1s pathway in mediating metabolic adaptation in epithelial plasticity. | Nucleic Acids Res | 2023 | 36772828 | PubTator, text mining | PubMed |
| Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting. | Int J Mol Sci | 2023 | 36769263 | PubTator, text mining | PubMed |
| Aberrant phase separation and nucleolar dysfunction in rare genetic diseases. | Nature | 2023 | 36755093 | PubTator, text mining | PubMed |
| Interaction modules that impart specificity to disordered protein. | Trends Biochem Sci | 2023 | 36754681 | PubTator, text mining | PubMed |
| Signal-induced enhancer activation requires Ku70 to read topoisomerase1-DNA covalent complexes. | Nat Struct Mol Biol | 2023 | 36747093 | PubTator, text mining | PubMed |
| Expression of integrin β-7 is epigenetically enhanced in multiple myeloma subgroups with high-risk cytogenetics. | Clin Epigenetics | 2023 | 36737807 | PubTator, text mining | PubMed |
| Nuclear condensates of YAP fusion proteins alter transcription to drive ependymoma tumourigenesis. | Nat Cell Biol | 2023 | 36732631 | PubTator, text mining | PubMed |
| G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma. | Nat Commun | 2023 | 36732506 | PubTator, text mining | PubMed |
| Targeting super enhancers for liver disease: a review. | PeerJ | 2023 | 36726725 | PubTator, text mining | PubMed |
| Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. | Br J Cancer | 2023 | 36725920 | PubTator, text mining | PubMed |
| Superenhancers as master gene regulators and novel therapeutic targets in brain tumors. | Exp Mol Med | 2023 | 36720920 | PubTator, text mining | PubMed |
| Structural mechanism of BRD4-NUT and p300 bipartite interaction in propagating aberrant gene transcription in chromatin in NUT carcinoma. | Nat Commun | 2023 | 36690674 | PubTator, text mining | PubMed |
| Molecular Alterations and Putative Therapeutic Targeting of Planar Cell Polarity Proteins in Breast Cancer. | J Clin Med | 2023 | 36675340 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5469/papers?page=17